Get the Stockscreener App
45.46
3.18%
1.40
After Hours:
46.39
0.93
+2.05%
Hims Hers Health Inc stock is traded at $45.46, with a volume of 21.68M.
It is up +3.18% in the last 24 hours and down -19.85% over the past month.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
See More
Previous Close:
$44.06
Open:
$45.365
24h Volume:
21.68M
Relative Volume:
0.76
Market Cap:
$9.89B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
65.88
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
-6.81%
1M Performance:
-19.85%
6M Performance:
+37.34%
1Y Performance:
+141.42%
1-Day Range:
$45.00
$47.24
1-Week Range:
$44.05
$50.19
52-Week Range:
$18.70
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
45.46 | 9.96B | 1.78B | 164.40M | 236.51M | 0.69 |
|
ZTS
Zoetis Inc
|
144.09 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.44 | 41.80B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.27 | 40.88B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.48 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
445.43 | 19.53B | 3.08B | 1.24B | 1.07B | 25.61 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-21-25 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-23-25 | Downgrade | Needham | Buy → Hold |
| Jun-04-25 | Reiterated | Needham | Buy |
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Hims & Hers Health (HIMS) Q3 Earnings Preview: Revenue Growth An - GuruFocus
Promising Healthcare Stocks To Watch NowNovember 2nd - MarketBeat
State of Michigan Retirement System Grows Stock Holdings in Hims & Hers Health, Inc. $HIMS - MarketBeat
Retirement Systems of Alabama Purchases 6,930 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
New York Life Investment Management LLC Takes $963,000 Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health (HIMS) Q3 Earnings: What To Expect - Barchart.com
Top Healthcare Stocks To ConsiderNovember 1st - MarketBeat
Yong Rong HK Asset Management Ltd Sells 1,450,200 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Nisa Investment Advisors LLC Acquires 14,106 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Stock Up on JPMorgan Stake, GLP-1 ExpansionNews and Statistics - IndexBox
Privia Health's Premium: A Breakout Play (PRVA) - Seeking Alpha
Why Hims & Hers Health (HIMS) Stock Is Trading Up Today - Yahoo Finance
Hims & Hers Scales AI-Driven Personalized Health and Wellness - The Globe and Mail
Promising Healthcare Stocks Worth WatchingOctober 31st - MarketBeat
Hims & Hers rises after JPMorgan ups position - Sherwood News
Hims & Hers Q3 Preview: Growth Faces a Confidence Test - TradingView
Is There An Opportunity With Hims & Hers Health, Inc.'s (NYSE:HIMS) 26% Undervaluation? - 富途牛牛
Top digital health funding: Hims co-founder launches new startup - Modern Healthcare
Healthcare Stocks To Follow TodayOctober 30th - MarketBeat
Ethic Inc. Buys Shares of 7,048 Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health (NYSE:HIMS) Insider Soleil Boughton Sells 2,637 Shares - MarketBeat
LEVI & KORSINSKY ISSUES CORRECTION: Securities Fraud Class Action Against Hims & Hers Health, Inc. - PR Newswire
Best Healthcare Stocks To Add to Your WatchlistOctober 29th - MarketBeat
Can Sustained Product Demand Drive HIMS Stock Before Q3 Earnings? - Yahoo Finance
Hims to begin selling GLP-1 microdosing treatments - Sherwood News
Microdosing Treatment Plans for Metabolic Health - Hims & Hers Newsroom
D.A. Davidson & CO. Invests $788,000 in Hims & Hers Health, Inc. $HIMS - MarketBeat
1 Profitable Stock on Our Watchlist and 2 We Find Risky - The Globe and Mail
Insider Sell: Soleil Boughton Sells Shares of Hims & Hers Health Inc (HIMS) - GuruFocus
Hims & Hers Health, Inc. (HIMS) Stock Dips While Market Gains: Key Facts - Yahoo Finance
Hims & Hers Health Stock (HIMS) Opinions on Menopause Care Launch - Quiver Quantitative
Hims & Hers Health, Inc. $HIMS Stock Holdings Increased by Y Intercept Hong Kong Ltd - MarketBeat
HIMS vs. LFMD: Which Telehealth Stock Is the Better Investment Now? - sharewise.com
Hims & Hers Health, Inc. (HIMS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release - Yahoo Finance
United Capital Management of KS Inc. Boosts Stock Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers Health (HIMS) Projected to Post Earnings on Monday - MarketBeat
First Citizens Bank & Trust Co. Makes New $571,000 Investment in Hims & Hers Health, Inc. $HIMS - MarketBeat
Forum Financial Management LP Acquires Shares of 8,037 Hims & Hers Health, Inc. $HIMS - MarketBeat
Is Hims & Hers Health Still a Smart Opportunity After 124% Stock Surge in 2025? - Yahoo Finance
Bleakley Financial Group LLC Acquires Shares of 38,474 Hims & Hers Health, Inc. $HIMS - MarketBeat
Allianz Asset Management GmbH Sells 43,929 Shares of Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers: Pioneering Customer-Centric Innovation with Premium Valuation - FXLeaders
Hims & Hers: Use This Drop Before It's Too Late (NYSE:HIMS) - Seeking Alpha
Hims & Hers Short Interest Nears All-Time High, Buy The Dip? - MarketBeat
Menopause Care Expansion Could Be a Game Changer for Hims & Hers Health (HIMS) - simplywall.st
Carnegie Investment Counsel Trims Position in Hims & Hers Health, Inc. $HIMS - MarketBeat
Shattering the Stigma around Menopause with Molly Sims in New York City - Hims & Hers Newsroom
Telehealth Stock Could Rebound Off Long-Term Trendline - Schaeffer's Investment Research
VIRGINIA RETIREMENT SYSTEMS ET Al Purchases New Shares in Hims & Hers Health, Inc. $HIMS - MarketBeat
Hims & Hers: There's Opportunity In This Crash (Upgrade) - Seeking Alpha
Hims & Hers Health, Inc. (HIMS) Stock forecasts - Yahoo
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.86%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):